Article info

Original research
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Authors

  • Evan Rosenbaum Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Cristina R Antonescu Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Shaleigh Smith Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articlesGoogle scholar articles
  • Martina Bradic Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articlesGoogle scholar articles
  • Daniel Kashani Department of Medicine, SUNY Downstate Medical Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Allison L Richards Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articlesGoogle scholar articles
  • Mark Donoghue Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articlesGoogle scholar articles
  • Ciara M Kelly Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Benjamin Nacev Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Jason E Chan Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Ping Chi Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USAHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA PubMed articlesGoogle scholar articles
  • Mark A Dickson Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Mary L Keohan Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Mrinal M Gounder Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Sujana Movva Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Viswatej Avutu Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Katherine Thornton Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Ahmet Zehir Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Anita S Bowman Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Samuel Singer Department of Surgery, Memorial Sloan Kettering Cancer Center, New York City, New York, USA PubMed articlesGoogle scholar articles
  • William Tap Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  • Sandra D’Angelo Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USADepartment of Medicine, Weill Cornell Medical College, New York City, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Evan Rosenbaum; rosenbae{at}mskcc.org
View Full Text

Citation

Rosenbaum E, Antonescu CR, Smith S, et al
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center

Publication history

  • Accepted March 12, 2022
  • First published April 1, 2022.
Online issue publication 
August 25, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.